Literature DB >> 17990355

Novel translational strategies in colorectal cancer research.

Ignacio Gil-Bazo1.   

Abstract

Defining translational research is still a complex task. In oncology, translational research implies using our basic knowledge learnt from in vitro and in vivo experiments to directly improve diagnostic tools and therapeutic approaches in cancer patients. Moreover, the better understanding of human cancer and its use to design more reliable tumor models and more accurate experimental systems also has to be considered a good example of translational research. The identification and characterization of new molecular markers and the discovery of novel targeted therapies are two main goals in colorectal cancer translational research. However, the straightforward translation of basic research findings, specifically into colorectal cancer treatment and vice versa is still underway. In the present paper, a summarized view of some of the new available approaches on colorectal cancer translational research is provided. Pros and cons are discussed for every approach exposed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17990355      PMCID: PMC4205436          DOI: 10.3748/wjg.v13.i44.5902

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  112 in total

Review 1.  Protein microarrays and proteomics.

Authors:  Gavin MacBeath
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

2.  Automated acquisition of stained tissue microarrays for high-throughput evaluation of molecular targets.

Authors:  Hans Vrolijk; Willem Sloos; Wilma Mesker; Patrick Franken; Riccardo Fodde; Hans Morreau; Hans Tanke
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

Review 3.  A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies.

Authors:  Lynn R Zieske
Journal:  J Exp Bot       Date:  2006-03-30       Impact factor: 6.992

Review 4.  Advances in the treatment of metastatic colorectal cancer.

Authors:  Richard M Goldberg
Journal:  Oncologist       Date:  2005

5.  Electrospray interface for liquid chromatographs and mass spectrometers.

Authors:  C M Whitehouse; R N Dreyer; M Yamashita; J B Fenn
Journal:  Anal Chem       Date:  1985-03       Impact factor: 6.986

Review 6.  RNAi: a novel antisense technology and its therapeutic potential.

Authors:  Anne Dallas; Alexander V Vlassov
Journal:  Med Sci Monit       Date:  2006-03-28

7.  New targets and challenges in the molecular therapeutics of cancer.

Authors:  Alan Eastman; Raymond P Perez
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

8.  Preliminary proteomic analysis of indomethacin's effect on tumor transplanted with colorectal cancer cell in nude mice.

Authors:  Yu-Jie Wang; Gui-Ying Zhang; Zhi-Qiang Xiao; Hong-Mei Wang; Zhu-Chu Chen
Journal:  J Biochem Mol Biol       Date:  2006-03-31

9.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

10.  Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.

Authors:  I Fichtner; W Slisow; J Gill; M Becker; B Elbe; T Hillebrand; M Bibby
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

View more
  1 in total

Review 1.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.